首页>
外国专利>
CELLULES PRÉSENTATRICES D'ANTIGÈNE ARTIFICIELLES UTILISÉES POUR L'EXPANSION DE CELLULES IMMUNITAIRES POUR L'IMMUNOTHÉRAPIE
CELLULES PRÉSENTATRICES D'ANTIGÈNE ARTIFICIELLES UTILISÉES POUR L'EXPANSION DE CELLULES IMMUNITAIRES POUR L'IMMUNOTHÉRAPIE
展开▼
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed herein are methods of expanding immune cells for immunotherapy using artificial antigen presenting cells (aAPCs) having on their surface antibodies or ligands that bind molecules of both the T cell activation pathway and T cell costimulation pathway. The disclosed aAPCs can also secrete antibodies that bind molecules of the T cell inhibitory pathway. For example, anti-CD3 scFv on the surface of the aAPCs can bind and activate T cells, while anti-CD28 scFv and 4-1BBL on the surface of the aAPCs can provide dual co-stimulation for the T cells resulting in decreased levels of the markers CD25, TIM3, LAG3, and PD1. For example, blocking PD1/PDL1 ligation can limit suppression that is mediated by the tumor microenvironment. This is a less costly and more efficient alternative to peripheral blood mononuclear cells (PBMCs) and cytokine treatments that result in better quality T cell for adoptive transfer back into patients.
展开▼